Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

All numbers in thousands USD
Period Ending
31 Jan 2024
31 Jan 2023
31 Jan 2022
31 Jan 2021
Total Revenue
60,922,000
26,974,000
26,914,000
16,675,000
Cost of Revenue
774,000
1,040,000
9,439,000
6,279,000
Gross Profit
60,148,000
15,356,000
17,475,000
10,396,000
Operating Expenses
Research Development
--
7,339,000
5,268,000
3,924,000
Selling General and Administrative
--
14,058,000
2,166,000
1,940,000
Non Recurring
--
--
--
--
Others
2,933,000
(10,265,000)
0
0
Total Operating Expenses
2,933,000
11,132,000
7,434,000
5,864,000
Operating Income or Loss
32,972,000
4,224,000
10,041,000
4,532,000
Income from Continuing Operations
Total Other Income/Expenses Net
(338,000)
48,000
107,000
4,000
Earnings Before Interest And Taxes
33,310,000
4,443,000
10,177,000
4,593,000
Interest Expense
--
--
236,000
184,000
Income Before Tax
33,310,000
4,181,000
9,941,000
4,409,000
Income Tax Expense
(2,499,000)
(187,000)
189,000
77,000
Minority Interest
--
--
--
--
Net Income From Continuing Ops
29,760,000
4,368,000
9,752,000
4,332,000
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
29,760,000
4,368,000
9,752,000
4,332,000
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
29,760,000
7,074,000
9,752,000
4,332,000